From Restoring Sight to Reimagining the Brain, with Max Hodak
Episode
31 min
Read time
2 min
Topics
Startups, Leadership, Marketing
AI-Generated Summary
Key Takeaways
- ✓Retinal Prosthesis Commercial Pathway: Prima's current approved version addresses hundreds of thousands of patients in the US and Europe, with the next-generation device targeting millions. Pricing precedents in the field run high — a comparable earlier device billed roughly $150,000 per patient, and an approved gene therapy reimburses at nearly $500,000 per eye.
- ✓Platonic Representation Hypothesis as BCI Signal: AI model internal representations and biological brain neural recordings share measurable geometric alignment. Science Corp uses this alignment constructively — matching animal brain recordings to AI model activations — as evidence that large AI models are converging on a true underlying data structure, not a performance ceiling.
- ✓Brain-as-Computer Framework for Medical Device Development: Treating the brain as a computational system rather than a biological mystery produces faster, more predictable clinical results than small-molecule drug discovery. Deep brain stimulation and motor cortex implants can produce functional outcomes within an hour of activation, a timeline no drug trial can match.
- ✓Cognitive Bottleneck Limits Brain-Keyboard Products: Independent evidence triangulates human conscious information throughput at roughly 10 bits per second — demonstrated by memory recall experiments over Manhattan helicopter rides. Hodak argues this bottleneck means BCI-to-AI communication products offer marginal gains over typing or speech, making them a lower-priority product category.
- ✓Substrate Independence as the Unifying Mission: Science Corp's three-program pipeline — retinal prosthesis, biohybrid neural interfaces using engrafted living neurons, and perfusion medicine — targets a 10-to-15-year horizon. The goal is reducing biological fragility by making the brain's computational substrate separable from the body's organ systems, starting with vision and expanding to cardiovascular and cancer vulnerabilities.
What It Covers
Max Hodak, founder and CEO of Science Corp and former Neuralink co-founder, discusses Prima, a subretinal prosthesis chip that received European marketing approval in July 2024, the computational framework for understanding the brain, and Science Corp's long-term roadmap toward substrate independence for human consciousness.
Key Questions Answered
- •Retinal Prosthesis Commercial Pathway: Prima's current approved version addresses hundreds of thousands of patients in the US and Europe, with the next-generation device targeting millions. Pricing precedents in the field run high — a comparable earlier device billed roughly $150,000 per patient, and an approved gene therapy reimburses at nearly $500,000 per eye.
- •Platonic Representation Hypothesis as BCI Signal: AI model internal representations and biological brain neural recordings share measurable geometric alignment. Science Corp uses this alignment constructively — matching animal brain recordings to AI model activations — as evidence that large AI models are converging on a true underlying data structure, not a performance ceiling.
- •Brain-as-Computer Framework for Medical Device Development: Treating the brain as a computational system rather than a biological mystery produces faster, more predictable clinical results than small-molecule drug discovery. Deep brain stimulation and motor cortex implants can produce functional outcomes within an hour of activation, a timeline no drug trial can match.
- •Cognitive Bottleneck Limits Brain-Keyboard Products: Independent evidence triangulates human conscious information throughput at roughly 10 bits per second — demonstrated by memory recall experiments over Manhattan helicopter rides. Hodak argues this bottleneck means BCI-to-AI communication products offer marginal gains over typing or speech, making them a lower-priority product category.
- •Substrate Independence as the Unifying Mission: Science Corp's three-program pipeline — retinal prosthesis, biohybrid neural interfaces using engrafted living neurons, and perfusion medicine — targets a 10-to-15-year horizon. The goal is reducing biological fragility by making the brain's computational substrate separable from the body's organ systems, starting with vision and expanding to cardiovascular and cancer vulnerabilities.
Notable Moment
Hodak challenges the common assumption that pre-verbal thought is richer than language. He argues the feeling of having a fully formed idea before writing it down is a cognitive illusion — and that sitting down to write is itself the thinking process, not a translation of it.
Episode Transcript
The brain very literally, very clearly, plainly is a computer. You can solve computational problems by arranging matter in a certain way and then, like, taking your hands off and pressing go. We talk about being a brain in a vat. That's what the skull is. Like, the brain is connected to the environment through a small number of wires, the cranial and spinal nerves. These little cables that carry your interaction with the world. If you can get the visual signal, auditory signal, balance, motor, in and out of the brain, that is an end in itself. That is the central object. The retinal prosthesis right now, I think, is a great proof of concept that we're on the right track. Nobody had previously ever been able to restore a form vision image in the mind's eye of a of a blind patient in this way. We need to add depth of grayscale. We think we could see a path to get at least red and green. And so there's ways that we can compound upon this path through an engineering process to make a product that's better and better. Hi, listeners. Welcome back to no priors. Today, I'm here with Max Hodak, the founder and CEO of CYENS, formerly of Neuralink. We talk about Prima, the implant that helps people who have gone blind see again, which just got regulatory approval in Europe. Their quest to sustain the human experience and substrate independence for the brain. We also talk about alignable representations between AI models and the future of neuroscience. Welcome, Max. Max, thanks so much for doing this. Thanks for having me. So for anyone who is not familiar with science, can you just describe a little bit about, you know, why you start the company, leaving Neuralink, what the mission is? Fundamentally, we're a medical device company. But I think if, like, the mission of lowercase s science is to use a differentiated understanding of the universe to improve the human condition, I mean, that's that's the mission of uppercase s science. That's what we do. We use, specifically an understanding of how to work with the brain to get big effect sizes that you don't get in medicine often. Our main product is a retinal prosthesis. You can think of it like a cochlear implant for the eye. Cochlear implants are some of the biggest impacts in in all of medicine. I mean, you can if you've ever seen a video of a newborn turning on, turning it on for the first time, it's striking. And our goal is to to build things like that, including our primo retinal prosthesis. And for people who are not familiar with that, it's a chip Yes. That's inserted with glasses. It's so it's a tiny chip that's implanted under the retina in the back of the eye for patients that have gone blind due to loss of the light sensitive cells in the eye. So, specifically, this is …
Get the full transcript (6,323 words) + summary by email — free
One-time email with the complete transcript and AI summary of this episode. No account needed.
One email, no spam. We’ll also show you what SignalCast does.
Browse all No Priors: Artificial Intelligence | Technology | Startups transcripts →
You just read a 3-minute summary of a 28-minute episode.
Get No Priors: Artificial Intelligence | Technology | Startups summarized like this every Monday — plus up to 2 more podcasts, free.
Pick Your Podcasts — FreeKeep Reading
More from No Priors: Artificial Intelligence | Technology | Startups
What Chess.com Teaches US About Superhuman Capabilities, with CEO Erik Allebest
Aug 13 · 46 min
a16z Podcast
The New Rules of Media | Marc Andreessen & Ben Horowitz
Jun 19
More from No Priors: Artificial Intelligence | Technology | Startups
Chasing Trillion-Dollar Companies, Founder Ambition, Token Budgets, and Regulatory Capture with Sarah & Elad
Aug 6 · 39 min
The Mel Robbins Podcast
If Nothing Seems to Be Going Your Way, Listen to This
Mar 26
More from No Priors: Artificial Intelligence | Technology | Startups
We summarize every new episode. Want them in your inbox?
What Chess.com Teaches US About Superhuman Capabilities, with CEO Erik Allebest
Chasing Trillion-Dollar Companies, Founder Ambition, Token Budgets, and Regulatory Capture with Sarah & Elad
Building an Autonomous Enterprise for Real-World Services with Netic Founder Melisa Tokmak
Building an Autonomous Delivery Experience with DoorDash Co-Founders Andy Fang and Stanley Tang
Travel Through the Lens of AI with with Booking.com CEO Glenn Fogel
Similar Episodes
Related episodes from other podcasts
a16z Podcast
Jun 19
The New Rules of Media | Marc Andreessen & Ben Horowitz
The Mel Robbins Podcast
Mar 26
If Nothing Seems to Be Going Your Way, Listen to This
Business Of Biotech
Feb 23
An Anthropological Lens On Leadership In Life Sciences With Bunka's Monika Sumra, Ph.D.
In Good Company with Nicolai Tangen
Jan 21
Mala Gaonkar: Building SurgoCap, Identifying Great Businesses and Learning from Mistakes
Eye on AI
Aug 19
From Zero to 150 Robots in Just 20 Months | Mike LeBlanc, Foundation Future Industries
Explore Related Topics
This podcast is featured in Best AI Podcasts (2026) — ranked and reviewed with AI summaries.
Read this week's Startups & Product Podcast Insights — cross-podcast analysis updated weekly.
You're clearly into No Priors: Artificial Intelligence | Technology | Startups.
Every Monday, we deliver AI summaries of the latest episodes from No Priors: Artificial Intelligence | Technology | Startups and 192+ other podcasts. Free for one show.
Start My Monday DigestNo credit card · Unsubscribe anytime